There is no excerpt because this is a protected post.ML6710iModulight's cloud-connected ophthalmic laser platformML6710i is a medical laser device for ophthalmology. ML6710i is designed for treatments in various ophthalmic indications. The laser is controlled intuitively from iPad app – the wireless connection allows flexibility for the treatment setup. A must-have tool for anyone in the field of ophthalmology. The laser beam is formed into a circular, adjustable and highly uniform spot by Modulight’s laser beam shaper. Ophthalmologists operating Modulight's ML6710i Request quotation!Designed for Retina Every part and feature within ML6710i is designed to fulfill
Continue reading →
There is no excerpt because this is a protected post.Customer case Erasmus MC is the largest and one of the best University Medical Centers in Europe. Modulight products: ML7710 (689 nm) Laser use: Activation of antibody-IRDye700DX conjugates for photoimmunotherapy of cancer. Link to the study: Dominic Robinson (PI) Research Research centered on PDT encompasses 3 main themes: Understanding the mechanism of action/theoretical bases of PDT Developing technology for PDT dosimetry/treatment monitoring Receptor targeted PDT/PIT. Main indications of interest are dermatology, gastroenterology and H&N cancer. Most recently the group has investigated mechanisms & effectiveness
Continue reading →
There is no excerpt because this is a protected post.Customer case Research in close collaboration with University Medical Center Utrecht, Erasmus Medical Center and Leiden University Medical Center. Research focused on the efficacy and mechanisms of targeted cancer photoimmunotherapy using nanobodies (antibody fragments). The advantage of nanobodies lies in the combination of their small molecular size, with high binding affinity for their targets, resulting to high accumulation at the tumor site, better tumor penetration and faster clearance from blood circulation. The aim is to target therapy to cancer cell-expressing antigens like EGFR (H&N cancer)
Continue reading → 
